Item Details
QIAGEN’s Proposed €9.6 Billion Takeover Requires Transaction and Compliance Planning
On 21 October, EQT’s acquisition vehicle announced a voluntary cash offer of €46.50 per QIAGEN share, valuing the Dutch-headquartered life-sciences company’s equity at approximately €9.6 billion. The takeover is proposed, and no separate legal-advisory or compliance-services contract price was disclosed. Corporate legal teams, investors and compliance advisers can explore digital due diligence, document analytics and transaction-monitoring workflows; HPC can support secure data processing and audit reporting, with quotations based on the confirmed engagement scope.
Get in Touch
We’ll get back to you shortly.